Filter by: patients
Home > Community Treatment Reports and Side Effects > L-Methionine Treatment Report
What is L-Methionine?

Methionine is one of the essential sulfur amino acids and plays a key role in regulating the availability of folic acid.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Other 1 1 Efficacy_cant_tell
( joint deterioration) 1 1 Efficacy_major
Myelopathy 1 1 Efficacy_cant_tell
ALS (Amyotrophic Lateral Sclerosis) 1 0

See all 4 patients currently taking L-Methionine

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 1
None
 2

Commonly reported side effects, conditions, and hospitalizations associated with L-Methionine

Rash or skin problems 1

Reported Dosages

  500 mg every other week 520 mg daily 1,206 mg daily 2,400 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking L-Methionine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 1   Did not seem to work: 100%

See all 1 patient who’ve stopped taking L-Methionine

Reported Duration See details about how long patients take this treatment ▼

Currently Taking L-Methionine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Stopped Taking L-Methionine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of L-Methionine

Always
 2 67%
Usually
 0 0%
Sometimes
 1 33%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of L-Methionine

Very
 0 0%
Somewhat
 1 33%
A little
 0 0%
Not at all
 2 67%

Cost

Paid out of pocket

Cost of L-Methionine

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 2 100%

Report created on May 27, 2012.